Drug Trial Radar · NCT06544616
A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
55
Actual
Start
Jul 22, 2024
Primary completion
Dec 22, 2026
Study completion Jan 5, 2027
Sponsor
- Lead sponsor
- Janssen Pharmaceutica N.V., BelgiumJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Aug 9, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 55 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess whether JNJ-64042056 affects the spread and build up of tau (a protein in brain) when compared with placebo, using brain scan (tau PET) to determine results from specific areas of the brain.
Conditions
- Alzheimer Disease
Interventions
JNJ-64042056Drug
JNJ-64042056 will be administered intramuscularly.
PlaceboDrug
Placebo will be administered intramuscularly.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Brain Tau Burden as Measured by Tau PET in Specified Regions of Interest (ROI)Time frame: Baseline up to Week 102
Locations
90 sites in 9 countries. Site status is shown where the registry gives one.
Xenoscience Inc.
Phoenix, Arizona
Irvine Clinical Research
Irvine, California
Esperanza Clinical
Murrieta, California
Artemis Institute for Clinical Research Riverside
Riverside, California
Artemis Institute for Clinical Research San Diego
San Diego, California
Yale University School Of Medicine
New Haven, Connecticut
JEM Research LLC
Atlantis, Florida
Excel Medical Clinical Trials, LLC
Boca Raton, Florida
K2 Medical Research Winter Garden
Clermont, Florida
Clinical NeuroScience Solutions Inc
Jacksonville, Florida
K2 Medical Research Lady Lake
Lady Lake, Florida
K2 Medical Research Maitland
Maitland, Florida
Merritt Island Medical Research, LLC
Merritt Island, Florida
Headlands Research Orlando
Orlando, Florida
Alzheimers Research and Treatment Center Stuart
Stuart, Florida
K2 Medical Research Tampa
Tampa, Florida
Charter Research
The Villages, Florida
Alzheimers Research and Treatment Center Wellington
Wellington, Florida
Palm Beach Neurology and Premier Research Institute
West Palm Beach, Florida
Great Lakes Clinical Trials Chicago
Chicago, Illinois
Great Lakes Clinical Trials Gurnee
Gurnee, Illinois
Quest Research Institute
Farmington Hills, Michigan
Hattiesburg Clinic
Hattiesburg, Mississippi
The Cognitive and Research Center of New Jersey LLC
Springfield, New Jersey
Neurological Associates of Albany, PC
Albany, New York
Velocity Clinical Research East Syracuse
East Syracuse, New York
The Medical Research Network, LLC
New York, New York
AMC Research, LLC
Matthews, North Carolina
Valley Medical Research
Centerville, Ohio
Keystone Clinical Studies LLC
Plymouth Meeting, Pennsylvania
Butler Hospital
Providence, Rhode Island
Clinical Trials of Texas Inc
San Antonio, Texas
Memory Clinic Inc
Bennington, Vermont
University of Virginia
Charlottesville, Virginia
Neuro Trials Victoria
Carlton, Australia
The Prince Charles Hospital
Chermside, Australia
St Vincent's Centre for Applied Medical Research
Darlinghurst, Australia
Austin Health Heidelberg Repatriation Hospital
Ivanhoe, Australia
Southern Neurology
Kogarah, Australia
KaRa Institute of Neurological Diseases
Macquarie Park, Australia
Showing 40 of 90 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.